Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 464

1.

Aggressive multi-visceral pancreatic resections for locally advanced neuroendocrine tumours. Is it worth it?

Abu Hilal M, McPhail MJ, Zeidan BA, Jones CE, Johnson CD, Pearce NW.

JOP. 2009 May 18;10(3):276-9.

2.

Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.

Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT.

Arch Surg. 2003 Aug;138(8):859-66.

PMID:
12912744
3.

Resection of pancreatic neuroendocrine tumors: results of 70 cases.

Kazanjian KK, Reber HA, Hines OJ.

Arch Surg. 2006 Aug;141(8):765-9; discussion 769-70.

PMID:
16924083
4.

[Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].

Ridwelski K, Meyer F, Schmidt U, Lippert H.

Zentralbl Chir. 2005 Aug;130(4):353-61. German.

PMID:
16103961
5.

Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.

Matthews BD, Heniford BT, Reardon PR, Brunicardi FC, Greene FL.

Am Surg. 2000 Dec;66(12):1116-22; discussion 1122-3.

PMID:
11149582
6.

Extended surgery for advanced pancreatic endocrine tumours.

Kleine M, Schrem H, Vondran FW, Krech T, Klempnauer J, Bektas H.

Br J Surg. 2012 Jan;99(1):88-94. doi: 10.1002/bjs.7681. Epub 2011 Aug 30.

PMID:
22135173
7.

Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable?

Teh SH, Deveney C, Sheppard BC.

Am J Surg. 2007 May;193(5):610-3; discussion 613.

PMID:
17434366
8.

Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.

Adham M, Jaeck D, Le Borgne J, Oussoultzouglou E, Chenard-Neu MP, Mosnier JF, Scoazec JY, Mornex F, Partensky C.

Pancreas. 2008 Nov;37(4):352-7. doi: 10.1097/MPA.0b013e31818166d2.

PMID:
18665012
9.

Cytoreductive surgery in advanced endocrine tumours of the pancreas.

Pederzoli P, Falconi M, Bonora A, Salvia R, Sartori N, Contro C, Marcucci S, Bassi C.

Ital J Gastroenterol Hepatol. 1999 Oct;31 Suppl 2:S207-12.

PMID:
10604132
10.

[Risk and follow-up after multi-visceral resections including the left side of the pancreas].

Böttger T, Boddin J, Heintz A, Junginger T.

Zentralbl Chir. 1995;120(10):804-8. German.

PMID:
7502597
11.

Pancreatic resection for M1 pancreatic ductal adenocarcinoma.

Shrikhande SV, Kleeff J, Reiser C, Weitz J, Hinz U, Esposito I, Schmidt J, Friess H, Büchler MW.

Ann Surg Oncol. 2007 Jan;14(1):118-27. Epub 2006 Oct 25.

PMID:
17066229
12.

Pancreatic resection for locally advanced primary and metastatic nonpancreatic neoplasms.

Pingpank JF Jr, Hoffman JP, Sigurdson ER, Ross E, Sasson AR, Eisenberg BL.

Am Surg. 2002 Apr;68(4):337-40; discussion 340-1.

PMID:
11952243
13.

Second-look operation for unresectable pancreatic ductal adenocarcinoma at a high-volume center.

Michalski CW, Kleeff J, Bachmann J, Alkhatib J, Erkan M, Esposito I, Hinz U, Friess H, Büchler MW.

Ann Surg Oncol. 2008 Jan;15(1):186-92. Epub 2007 Oct 18.

14.

Benefit of venous resection for ductal adenocarcinoma of the pancreatic head.

Hartel M, Niedergethmann M, Farag-Soliman M, Sturm JW, Richter A, Trede M, Post S.

Eur J Surg. 2002;168(12):707-12.

PMID:
15362580
15.

En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.

Yekebas EF, Bogoevski D, Cataldegirmen G, Kunze C, Marx A, Vashist YK, Schurr PG, Liebl L, Thieltges S, Gawad KA, Schneider C, Izbicki JR.

Ann Surg. 2008 Feb;247(2):300-9. doi: 10.1097/SLA.0b013e31815aab22.

PMID:
18216537
16.

Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update.

van Geenen RC, van Gulik TM, Offerhaus GJ, de Wit LT, Busch OR, Obertop H, Gouma DJ.

Eur J Surg Oncol. 2001 Sep;27(6):549-57.

PMID:
11520088
17.

Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head.

Leach SD, Lee JE, Charnsangavej C, Cleary KR, Lowy AM, Fenoglio CJ, Pisters PW, Evans DB.

Br J Surg. 1998 May;85(5):611-7.

PMID:
9635805
18.

Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes.

Martin RC 2nd, Scoggins CR, Egnatashvili V, Staley CA, McMasters KM, Kooby DA.

Arch Surg. 2009 Feb;144(2):154-9. doi: 10.1001/archsurg.2008.547.

PMID:
19221327
19.

Bypass surgery versus palliative pancreaticoduodenectomy in patients with advanced ductal adenocarcinoma of the pancreatic head, with an emphasis on quality of life analyses.

Schniewind B, Bestmann B, Kurdow R, Tepel J, Henne-Bruns D, Faendrich F, Kremer B, Kuechler T.

Ann Surg Oncol. 2006 Nov;13(11):1403-11. Epub 2006 Sep 29.

PMID:
17009141
20.

[Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].

Fendrich V, Habbe N, Celik I, Langer P, Zielke A, Bartsch DK, Rothmund M.

Dtsch Med Wochenschr. 2007 Feb 2;132(5):195-200. German.

PMID:
17252361

Supplemental Content

Support Center